Related Experiment Videos

Variability in nucleotide excision repair and cancer risk: a review

S Benhamou1, A Sarasin

  • 1Unit of Cancer Epidemiology, INSERM U521, Institut Gustave Roussy, 39 rue Camille Desmoulins, Villejuif, France.

Mutation Research
|April 18, 2000
PubMed

Insights

This review highlights nucleotide excision repair (NER) assays for studying cancer risk. Reduced DNA repair efficiency is linked to skin cancers and smoking-related cancers.

Area of Science:

  • Molecular Biology
  • Genetics
  • Cancer Research

Background:

  • Cancer initiation involves mutations from unrepaired DNA lesions caused by genotoxins.
  • Nucleotide excision repair (NER) is crucial for removing bulky DNA adducts from carcinogens.
  • Xeroderma pigmentosum (XP) demonstrates the link between NER deficiency and high skin cancer risk.

Purpose of the Study:

  • To review NER assays used in epidemiological studies.
  • To investigate the association between DNA repair efficiency and cancer risk.

Main Methods:

  • Literature review of epidemiological studies utilizing NER assays.
  • Analysis of associations between DNA repair capacity and various cancer types.

Main Results:

  • Reduced DNA repair efficiency may contribute to basal cell carcinoma (BCC) development, though findings are inconsistent.
  • Consistent associations were found between cellular sensitivity to genotoxins and smoking-related cancers.

Conclusions:

  • NER assays are valuable tools for cancer risk assessment.
  • DNA repair efficiency, particularly NER, plays a significant role in cancer development, especially for skin and smoking-related cancers.

Related Concept Videos